Differential effects of glucocorticoid and mineralocorticoid antagonism on anxiety behavior in mild traumatic brain injury

• Published in: Behavioural brain research 2016-10, Vol.312, p.362-365
• Main Authors: Fox, Laura C., Davies, Daniel R., Scholl, Jamie L., Watt, Michael J., Forster, Gina L.
• Format: Article
• Language: English
• Subjects: Animals; Anxiety; Anxiety - etiology; Anxiety - physiopathology; Anxiety - prevention & control; Brain Concussion - complications; Brain Concussion - physiopathology; Glucocorticoids; Male; Mifepristone - administration & dosage; Mild traumatic brain injury; Mineralocorticoid Receptor Antagonists - administration & dosage; Rat; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid - antagonists & inhibitors; Receptors, Glucocorticoid - physiology; Receptors, Mineralocorticoid - physiology; Spironolactone - administration & dosage; Stress; Stress, Psychological - physiopathology
• ISSN: 0166-4328; 1872-7549
• DOI: 10.1016/j.bbr.2016.06.048

•A novel rat model of social stress paired with mild brain injury was utilized.•Glucocorticoid receptor antagonism prevented anxiety induced by mild TBI.•Mineralocorticoid receptor blockade less effective at preventing mild TBI anxiety.•Results suggest targeting glucocorticoid receptors to treat symptoms of mild TBI. Mild traumatic brain injuries (TBIs) comprise three-quarters of all TBIs occurring in the United States annually, and psychological symptoms arising from them can last years after injury. One commonly observed symptom following mild TBI is generalized anxiety. Most mild TBIs happen in stressful situations (sports, war, domestic violence, etc.) when glucocorticoids are elevated in the brain at the time of impact, and glucocorticoids have negative effects on neuronal health following TBI. Therefore, blocking glucocorticoid receptors might prevent emergence of anxiety symptoms post-injury. Adult male rats received mifepristone (20mg/kg) or spironolactone (50mg/kg) to block glucocorticoid and mineralocorticoid receptors, respectively, 40min prior to being exposed to acute social defeat stress followed immediately by mild TBI. In defeated rats with concomitant mild TBI, mifepristone restored time spent in the open arms of an elevated plus maze to control levels, demonstrating for the first time that glucocorticoid receptors play a critical role in the development of anxiety after mild TBI. Future treatments could target these receptors, alleviating anxiety as a major side effect in victims of mild TBI sustained in stressful situations.